Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dexmedetomidine hydrochloride 0.1182 mg/ml equivalent to dexmedetomidine 0.1mg/ml - concentrate for injection - active: dexmedetomidine hydrochloride 0.1182 mg/ml equivalent to dexmedetomidine 0.1mg/ml excipient: sodium chloride water for injection - for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine hydrochloride ever pharma by continuous intubation in these patents should not exceed 24 hours. for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

attix pharmaceuticals - medetomidine hydrochloride (unii: bh210p244u) (medetomidine - unii:mr15e85mqm) -

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: nitrogen sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: nitrogen sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml - concentrate for infusion - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100 mg/1 ml excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - detomidine hydrochloride - unknown - detomidine hydrochloride imidazole active 0.0 - active constituent

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - medetomidine hydrochloride - unknown - medetomidine hydrochloride imidazole active 0.0 - active constituent